Foghorn Therapeutics (FHTX) Profit After Tax Growth (1y) (2020 - 2026)
Foghorn Therapeutics (FHTX) Profit After Tax Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 101.22% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Foghorn Therapeutics | 362.65 Mn | 273.74 Mn | - | -6.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.55% |
| Dec 31, 2025 | -4.91% |
| Sep 30, 2025 | 100.37% |
| Jun 30, 2025 | 21.95% |
| Mar 31, 2025 | 24.85% |
| Dec 31, 2024 | -127.42% |
| Sep 30, 2024 | -28.43% |
| Jun 30, 2024 | 22.07% |
| Mar 31, 2024 | 17.95% |
| Dec 31, 2023 | -6.78% |
| Sep 30, 2023 | -756.42% |
| Jun 30, 2023 | -7.96% |
| Mar 31, 2023 | -13.28% |
| Dec 31, 2022 | 377.56% |
| Sep 30, 2022 | 93.58% |
| Jun 30, 2022 | -18.18% |
| Mar 31, 2022 | -17.09% |
| Dec 31, 2021 | -40.32% |
| Sep 30, 2021 | -41.99% |
| Jun 30, 2021 | -46.99% |